VERA: Vera Therapeutics Inc - Class A

VERA新闻

• 20:16 Nvidia Unveils Its Full-Stack Blueprint to Contain and Monitor AI Agents
• 12:22 Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34
• 12:01 Alignment Healthcare、RenX Enterprises 及其他大盘股在周五盘前交易中走低
• 12:01 Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
• 13:28 Vera Therapeutics To Present Multiple Presentations At American Society Of Nephrology Kidney Week 2026 For Its Final Efficacy Analysis Of ORIGIN 3 Study Of TRUTAKNA In IgA Nephropathy
• 14:27 Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
• 00:01 Vera Therapeutics, Inc. (VERA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
• 19:36 Vera Therapeutics: Why I'm Sticking With 'Hold' Despite Positive Trutakna Data (VERA)
• 13:26 Vera Reverses Its Major Chart Upset As Vertex Rivalry Deepens — What Happened?
• 16:05 英伟达财报倒计时：Q2营收预期达922亿美元，AI算力霸主面临竞争与供应链考验
• 14:22 Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Movin
• 11:44 Nvidia denies launching China-specific AI chip before year-end: no such product in roadmap
• 18:20 Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy (NASDAQ:VERA)
• 19:10 Vera Therapeutics: A Crowded IgAN Market Leaves No Room For A Premium (Downgrade) (VERA)